GlassScriptPhysician profile
Zainab Ilahi
NPI 1639117666
$2,482.09
in general payments reported to CMS, 2019-2025
36 companies · $466 in 2025
The $466 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $568 · 2020: $12.09 · 2021: $39.25 · 2022: $349 · 2023: $413 · 2024: $635 · 2025: $466.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,414 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,414.16 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novocure INC. | $285.36 | 2019-2022 | |
| Ipsen Biopharmaceuticals, INC | $208.05 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $201.71 | 2019-2025 | |
| Pfizer INC. | $185.45 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $183.05 | 2019-2024 | Eliquis, Opdivo |
| Janssen Biotech, INC. | $160.16 | 2022-2025 | Imbruvica, Rybrevant |
| Myovant Sciences INC. | $134.93 | 2021-2022 | |
| Sirtex Medical INC | $128.29 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $94.07 | 2023-2025 | Enhertu, Imfinzi |
| Novartis Pharmaceuticals Corporation | $81.15 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $81.10 | 2023-2025 | Keytruda, Lynparza |
| Medtronic, INC. | $77.70 | 2023 | Osteocool Rf Ablation System |
| Incyte Corporation | $74.47 | 2023-2025 | Jakafi |
| Sobi, INC | $58.22 | 2023-2025 | |
| Iovance Biotherapeutics, INC. | $54.48 | 2025 | Amtagvi |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $47.78 | 2024 | Optablate |
| Regeneron Healthcare Solutions, INC. | $45.82 | 2023-2024 | Libtayo |
| Stemline Therapeutics INC. | $32.28 | 2024 | Orserdu |
| Alexion Pharmaceuticals, INC. | $25.49 | 2024 | Ultomiris |
| Adc Therapeutics America, INC. | $24.69 | 2025 | |
| Emd Serono, INC. | $23.54 | 2022 | |
| Immunocore Limited | $23.08 | 2025 | Kimmtrak |
| Daiichi Sankyo INC. | $22.69 | 2024 | Vanflyta |
| Eisai INC. | $22.69 | 2025 | |
| Taiho Oncology, INC. | $22.51 | 2025 | |
| Adaptive Biotechnologies Corporation | $22.46 | 2023 | Clonoseq |
| Legend Biotech USA INC. | $20.64 | 2025 | Carvykti |
| Alnylam Pharmaceuticals INC. | $20.34 | 2023 | Oxlumo |
| Amgen INC. | $18.60 | 2022 | |
| Genentech USA, INC. | $17.36 | 2024 | Phesgo |
| Pharmacyclics LLC, An Abbvie Company | $15.32 | 2021 | |
| Glaxosmithkline, LLC. | $14.96 | 2024 | Jemperli |
| Pharmacosmos Therapeutics INC. | $14.80 | 2025 | Monoferric |
| Lilly USA, LLC | $14.52 | 2022 | |
| Dova Pharmaceuticals | $12.24 | 2019 | |
| Advanced Accelerator Applications | $12.09 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zainab Ilahi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.